Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan;24(1):e16790.
doi: 10.1111/jocd.16790.

Emerging Roles of Dermal Fibroblasts in Hyperpigmentation and Hypopigmentation: A Review

Affiliations
Review

Emerging Roles of Dermal Fibroblasts in Hyperpigmentation and Hypopigmentation: A Review

Xingyue Gao et al. J Cosmet Dermatol. 2025 Jan.

Abstract

Background: Skin pigmentation disorders may increase patients' psychological burdens. Consequently, they are increasingly attracting attention. Dermal fibroblasts have been shown to regulate pigmentation by secreting soluble factors.

Aim: This study aimed to summarize recent findings on the effects of dermal fibroblasts on hyperpigmentation and hypopigmentation, enabling the discovery of new therapeutic targets.

Methods: PubMed was searched for literature on fibroblast factors, hyperpigmentation, and hypopigmentation, and a comprehensive summary and analysis were performed.

Results: Fibroblasts secrete both cytokines that promote pigmentation, including stem cell factor (SCF) and keratinocyte growth factor (KGF), and small amounts of those that inhibit pigmentation, such as Dickkopf1 (DKK1) and transforming growth factor (TGF)-β. Fibroblast-derived extracellular matrix (ECM) can also affect melanocyte tyrosinase activity and the transfer of melanosomes. In hyperpigmentation disorders, such as melasma and solar lentigines, the secretion of pigmentation-promoting factors increases, and the activity of key enzymes in melanin production is elevated. In hypopigmentation disorders, including vitiligo, the secretion of melanogenic factors decreases while the factors that inhibit pigmentation increase. Fibroblasts may serve as a new therapeutic target, providing new insights to precisely treat pigmentary disorders.

Conclusions: Fibroblasts synthesize and secrete various cytokines and proteins that modify melanin synthesis and transfer through different signaling pathways, playing prominent roles in pigmentary skin disorders, such as photoaging, melasma, solar lentigo, and vitiligo.

Keywords: cytokine; fibroblasts; melanocytes; pigmentation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Cytokines secreted by fibroblasts that promote pigmentation. Akt, protein kinase B; bFGF, basic fibroblast growth factor; ECM, extracellular matrix; EDN1, Endothelin 1; EDNRB, endothelin receptor B; GDF15, growth differentiation factor15; HGF, hepatocyte growth factor; JNK, c‐Jun N‐terminal kinase; KGF, keratinocyte growth factor; KGFR, keratinocyte growth factor receptor; NRG1, Neuregulin1; PI3K, phosphoinositide 3‐kinase; SCF, stem cell factor; SDF1, stromal‐derived factor 1; sFRP2, secreted frizzled‐related protein 2; WIF‐1, Wnt inhibitory factor‐1.
FIGURE 2
FIGURE 2
Cytokines secreted by fibroblasts that inhibit pigmentation. CLU, clusterin; DKK1, Dickkopf1; MITF, microphthalmia‐associated transcription factor; PAR‐2, Peroxisome Activator Receptor‐2; PKA, protein kinase A; PTN, Pleiotrophin; TGF‐β, Transforming growth factor‐β.

Similar articles

Cited by

References

    1. Wu Y., Yang Y., Lin Y., et al., “Emerging Role of Fibroblasts in Vitiligo: A Formerly Underestimated Rising Star,” Journal of Investigative Dermatology 144, no. 8 (2024): 1696–1706. - PubMed
    1. Bibeau K., Ezzedine K., Harris J. E., et al., “Mental Health and Psychosocial Quality‐of‐Life Burden Among Patients With Vitiligo: Findings From the Global VALIANT Study,” JAMA Dermatology 159, no. 10 (2023): 1124–1128. - PMC - PubMed
    1. Sarkar R., Bansal A., and Ailawadi P., “Future Therapies in Melasma: What Lies Ahead?,” Indian Journal of Dermatology, Venereology and Leprology 86, no. 1 (2020): 8–17. - PubMed
    1. Mohd Nor N. H., Berahim Z., Azlina A., Mokhtar K. I., and Kannan T. P., “Identification and Characterization of Intraoral and Dermal Fibroblasts Revisited,” Current Stem Cell Research & Therapy 12, no. 8 (2017): 675–681. - PubMed
    1. Bellei B. and Picardo M., “Premature Cell Senescence in Human Skin: Dual Face in Chronic Acquired Pigmentary Disorders,” Ageing Research Reviews 57 (2020): 100981. - PubMed

LinkOut - more resources